Faculty profile

Abhijat Kitchlu

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Abhijat Kitchlu

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
36 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,666

Citations

138

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors–related AKI
Nephrology Dialysis Transplantation · 2026 · senior author
Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study
Breast Cancer Research and Treatment · 2026

All 68 publications

Latest funding

Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)
CIHR · 2024 · Co-investigator
$1,526,176
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1)
CIHR · 2023 · Co-investigator
$566,099
Filling Knowledge Gaps for the Success of Ontario Renal Plan 3
CIHR · 2021 · Co-investigator
$1,143,676

All 9 grants and awards

68 publications.

Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors–related AKI

Blanchette PS, Reid J, Richard L, Shariff SZ, Raphael J, Earle CC, Garg AX, Kitchlu A

Nephrology Dialysis Transplantation20262 citationsSenior authorOpen Access

DOI: 10.1093/ndt/gfaf191

Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.

Abbaticchio A, Theodorlis M, Zlotnik N, Cross MS, Yazdani S, Kitchlu A, Wilson JA, Gagliardi AR, Battistella M

American journal of kidney diseases : the official journal of the National Kidney Foundation20261 citations

DOI: 10.1053/j.ajkd.2025.08.018 PMID: 41390146

Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study

Molnar AO, McArthur E, Bota SE, Stirling K, Romain J, Leong DP, Mukherjee SD, Kitchlu A, Walsh M

Breast Cancer Research and Treatment2026

DOI: 10.1007/s10549-026-07953-1

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Glicksman RM, Winter J, McPartlin A, Santiago AT, Wang K, Bernstein J, Dang J, Tsui G, Chung P, Mesci A, Gutierrez Valencia E, Raman S, Berlin A, Catton C, Bayley A, Warde P, Krishna S, Finelli A, Hamilton RJ, Pace KT, Kitchlu A, Helou J

International journal of radiation oncology, biology, physics2026Open Access

DOI: 10.1016/j.ijrobp.2025.11.005 PMID: 41290048

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Renaghan AD, Ostermann M, Ronco C, Ballen K, Cosmai L, Fenoglio R, Floris M, Forni LG, Gladstone DE, Glezerman IG, Goldstein SL, Gupta S, Herrmann SM, Jaimes EA, Jhaveri KD, Karam S, Kitchlu A, Landau HJ, Latcha S, Leaf DE, Lentini P, Małyszko J, Markowitz G, Murakami N, Pani A, Perazella MA, Rashidi A, Roccatello D, Sharon E, Sprangers B, Tesař V, Torres V, Wanchoo R, Whitman A, Workeneh BT, Zepeda-Orozco D, Rosner MH

Nature reviews. Nephrology2026

DOI: 10.1038/s41581-025-01031-3 PMID: 41361704

Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis.

Alasadi Y, Garcia JC, Arani N, Page V, Geng Y, Andersen CR, Tchakarov A, Kitchlu A, Mamlouk O, Abudayyeh A

Clinical kidney journal2026

DOI: 10.1093/ckj/sfaf373 PMID: 41788614

Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

Harel Z, Smyth B, Badve SV, Blum D, Beaubien-Souligny W, Silver SA, Clark E, Suri R, Mavrakanas TA, Sasal J

Journal of the American Society of Nephrology202522 citationsOpen Access

DOI: 10.1681/asn.0000000000000495

Medication Mindfulness: Implementation and Evaluation of a Single-Site, 6-Month Deprescribing Intervention for Patients on Hemodialysis.

Zlotnik N, Abbaticchio A, Theodorlis M, Cross MS, Kitchlu A, Wilson JA, Gagliardi AR, Battistella M

Kidney36020254 citationsOpen Access

DOI: 10.34067/kid.0000000884 PMID: 40569679

Chronic Kidney Disease or Hypertension After Childhood Cancer

Lebel A, Chanchlani R, Cockovski V, Dart A, Fleming AJ, Garg AX, Jeyakumar N, Kim K, Kitchlu A, McArthur E

JAMA Network Open20253 citationsOpen Access

DOI: 10.1001/jamanetworkopen.2025.8199 PMID: W4410484238

Clinical Integration and Evaluation of the STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) Intervention.

Abbaticchio A, Theodorlis M, Cross MS, Kitchlu A, Wilson JA, Sills L, Scott-Douglas N, Qirjazi E, Tonelli M, DeBusschere A, Wichart J, Defoe K, MacRae JM, Stigant CE, Martinusen DJ, Cheung AJ, Battistella M

Canadian journal of kidney health and disease20252 citationsOpen Access

DOI: 10.1177/20543581251393436 PMID: 41333972

Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)

Co-investigatorCIHR2024Project Grant

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Cardiovascular Events; Hemodialysis; Hyperphosphatemia

$1,526,176

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1)

Co-investigatorCIHR2023Project Grant

Principal investigators: Wald, Ron; Cherney, David Z; Clemens, Kristin K; Yau, Kevin

Keywords: Diabetes Mellitus; Dialysis; End-Stage Kidney Disease; Glp-1 Receptor Agonists; Pilot Rct

$566,099

Filling Knowledge Gaps for the Success of Ontario Renal Plan 3

Co-investigatorCIHR2021Project Grant

Principal investigators: Weir, Matthew A; Beaucage, Mary B; Blake, Peter G; Chanchlani, Rahul; Clark, Edward G; Clemens, Kristin K; Dixon, Stephanie N; Harel, Ziv; Jain, Arsh K; Molnar, Amber; Silver, Samuel; Sood, Manish M; Zappitelli, Michael

Keywords: Administrative Health Care Data; Chronic Kidney Disease; Community-Based Research; Drug Safety; First Nations Communities; Kidney Transplantation; Mental Health; Patient-Oriented Research; Population-Based Study

$1,143,676

Kidney and blood pressure disease burden and monitoring for chronic kidney disease in childhood cancer survivors

Co-investigatorCIHR2019Project Grant

Principal investigators: Zappitelli, Michael

Keywords: Administrative Health Care; Cancer Therapy; Children; Chronic Kidney Disease; Epidemology; Hypertension; Knowledge Translation; Long-Term Outcomes; Population-Based Study; Prospective Cohort

$929,478

Filling Knowledge Gaps for the Success of Ontario Renal Plan 3

Co-investigatorCIHR2019Project Grant - PA: Nutrition, Metabolism and Diabetes

Principal investigators: Weir, Matthew A; Beaucage, Mary B; Chanchlani, Rahul; Clark, Edward G; Clemens, Kristin K; Coghlan, Candice; Dixon, Stephanie N; Field, Bonnie; Harel, Ziv; Jain, Arsh K; Molnar, Amber; Silver, Samuel; Sood, Manish M; Zappitelli, Michael

$100,000

Innovative Pragmatic Cluster-Randomized Registry Trials to Improve Hemodialysis Care

Co-investigatorCIHR2019Operating Grant: SPOR Innovative Clinical Trial Multi-Year Grant

Principal investigators: Garg, Amit; Cote, Brenden B; Vorster, Arris H; Blake, Peter G; Bohm, Clara; Lacson, Jr., Eduardo; Levin, Adeera; Silver, Samuel; Tonelli, Marcello

Keywords: Comparative Effectiveness

$2,817,233

Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

Co-investigatorCIHR2018Project Grant

Principal investigators: Harel, Ziv; Wald, Ron

Keywords: Anticoagulation; Apixaban; Atrial Fibrillation; Direct Oral Anticoagulants; Feasibility; Hemodialysis; Warfarin

$314,416

Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)

Co-investigatorCIHR2018Project Grant

Principal investigators: Wald, Ron; Walsh, Michael W

Keywords: Dialysis; End-Stage Renal Disease; Phosphate; Randomized Control Trial

$1,526,175

Beta blockers, dialyzability and outcomes

Co-investigatorCIHR2011Operating Grant

Principal investigators: Weir, Matthew A; Garg, Amit

Keywords: Beta Blockers; Health Care Databases; Hemodialysis; Outcomes

$59,956

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Abhijat Kitchlu

Research

Latest papers

Latest funding

Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors–related AKI

Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.

Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis.

Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

Medication Mindfulness: Implementation and Evaluation of a Single-Site, 6-Month Deprescribing Intervention for Patients on Hemodialysis.

Chronic Kidney Disease or Hypertension After Childhood Cancer

Clinical Integration and Evaluation of the STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) Intervention.

Frequent collaborators

Ron Wald

Amit Garg

Samuel Silver

Ziv Harel

Neill Adhikari

Danielle Nash

S. Dixon

Stephanie Dixon

Rahul Chanchlani

Geoffrey Liu

Rulan Parekh

Chaim Bell

Marisa Battistella

Karen Burns

Paul Nathan

Jo-Anne Wilson

Jan Friedrich

Rohan John

Amber Molnar

Edward Clark

Anca Prica

Padraig Warde

Andrew McPartlin

Aruz Mesci

Ivan Pasic

Matthew Oliver

Elena Pope

Normand Blais

Anique Ducharme

Marie-Claude Parent

Louis Pinard

Virginie Royal

Lucie Richard

Bhanu Prasad